Panelists discuss how step-up dosing protocols reduce cytokine release syndrome (CRS) risk in patients with high-risk disease ...

Dual inhibition of IL-4 and IL-13 with dupilumab represents a very promising avenue for biologic-based asthma therapy, but further large-scale clinical trials on patients with day-to-day asthma ...

According to Elaine Fajardo, MD, Medical Director for Respiratory Therapy and Pulmonologist at Yale Medicine, and Assistant Professor at Yale School of Medicine, these are the general step-by-step ...

A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy ... now backing up those results in ...